@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix go: . @prefix Protein: . @prefix hgnc: . @prefix geneProductOf: . @prefix hasAgent: . @prefix obo: . @prefix occursIn: . @prefix species: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 hasAgent: sub:_2; a go:0016301 . sub:_2 geneProductOf: hgnc:6855; a Protein: . sub:_3 hasAgent: sub:_4; a go:0016301 . sub:_4 geneProductOf: hgnc:6881; a Protein: . sub:_5 occursIn: obo:CL_0000084, species:9606; rdf:object sub:_3; rdf:predicate belv:increases; rdf:subject sub:_1; a rdf:Statement . sub:assertion rdfs:label "kin(p(HGNC:MAP3K3)) -> kin(p(HGNC:MAPK8))" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_7; pav:version "20131211" . sub:_6 prov:value "Upon binding of IL-1 to IL-1RI, an IL-1RAcP is recruited to form a high affinity IL-1R1-IL-1RAcP heterodimeric receptor, which initiates the downstream signaling cascade. The trimeric complex rapidly assembles MyD88 and IRAK4 and forms a stable IL-1-induced first signaling module, which subsequently phosphorylates IRAK1 and IRAK2, and recruits TRAF6. Complexes of IRAK1, IRAK2 and TRAF6 dissociate from the initial receptor complex and promote TGF?-activated protein kinase (TAK)1/TAK-binding protein (TAB)1 association, which is followed by the activation of NF?B, JNK and p38 MAPK pathways. Activation of the IKK complex by IL-1 promotes I?B? ubiquitination. The nuclear translocation of NF?B with the nuclear translocation of c-JUN, induced by the activation of JNK and p38 MAPK, modulates the gene expression of IL-6, TNF?, IL-1?, IFN?, IFN? and TGF?. Multiple negative regulators of this pathway, including inhibitory IL-RII, secreted soluble (s)IL-1RI and sIL-RII, regulatory IL-1R1a and SIGIRR provide a negative feedback control of this pathway and suppress excessive IL-1 signaling."; prov:wasQuotedFrom pubmed:21776333 . sub:_7 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:21776333; prov:wasDerivedFrom beldoc:, sub:_6 . } sub:pubinfo { this: dct:created "2014-07-03T14:33:41.604+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }